Insider Transactions in Q2 2022 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
726
-1.35%
|
$2,904
$4.95 P/Share
|
|
Jun 14
2022
|
Joshua T Brumm CEO & President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,540
-1.68%
|
$14,160
$4.95 P/Share
|
|
Jun 14
2022
|
Wildon Farwell Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
668
-1.01%
|
$2,672
$4.95 P/Share
|
|
Jun 14
2022
|
Susanna Gatti High Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
802
-1.1%
|
$3,208
$4.95 P/Share
|
|
Jun 14
2022
|
Jonathan Mc Neill Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
504
-0.83%
|
$2,016
$4.95 P/Share
|
|
Jun 14
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
333
-1.23%
|
$1,332
$4.95 P/Share
|